Ansbert Gadicke, 10% Owner of Aktis Oncology AKTS, has filed 1 purchase and 33 sales on the open market. Over the past 12 months that comes to a net purchase of $17.8M. The latest trade was on 01/12.

Ansbert Gadicke

10% Owner

Company: Aktis Oncology AKTS
First filing: 23/05/24

Trades: 49 trades
Buys / sales: 1 / 33
12-month net buying: $17.8M
Last trade: 01/12

Trading activity

Transactions

	Trade type
Aktis OncologyAKTS	Open-market buy	01/12	01/14	1,112,777 sh	$18.00	$20,029,986	+12.2%
HOWL	Open-market sale10b5-1 plan	25/12/02–25/12/04	25/12/04	199,732 sh3 trades	$0.92avg.	$183,275.38	−4.0%
HOWL	Open-market sale10b5-1 plan	25/11/26–25/12/01	25/12/01	141,927 sh3 trades	$0.96avg.	$136,854.55	−2.8%
HOWL	Open-market sale10b5-1 plan	25/11/21–25/11/25	25/11/25	195,666 sh3 trades	$0.92avg.	$179,551.05	−3.7%
HOWL	Open-market sale10b5-1 plan	25/11/18–25/11/20	25/11/20	160,103 sh3 trades	$0.92avg.	$147,912.95	−2.9%
HOWL	Open-market sale10b5-1 plan	25/11/13–25/11/17	25/11/17	209,652 sh3 trades	$0.96avg.	$200,665.13	−3.7%
HOWL	Open-market sale10b5-1 plan	25/11/07–25/11/12	25/11/12	213,529 sh4 trades	$1.13avg.	$241,278.01	−3.6%
HOWL	Open-market sale10b5-1 plan	25/11/04–25/11/06	25/11/06	242,890 sh3 trades	$1.22avg.	$295,781.28	−4.0%
HOWL	Open-market sale10b5-1 plan	25/10/30–25/11/03	25/11/03	295,043 sh3 trades	$1.33avg.	$391,636.07	−4.6%
HOWL	Open-market sale10b5-1 plan	25/10/27–25/10/29	25/10/29	276,017 sh3 trades	$1.62avg.	$446,403	−4.1%
iTeos Therapeutics	Open-market sale	25/05/13	25/05/15	1,031,931 sh	$8.06	$8,317,363.86	−23.0%
Werewolf TherapeuticsHOWL	Open-market sale	25/03/27	25/04/30	4,386 sh	$1.05	$4,605.3	−0.1%
TRDA	Open-market sale	24/12/10–24/12/11	24/12/12	44,722 sh2 trades	$20.51avg.	$917,110.96	−1.0%
TCR2 Therapeutics	Open-market sale	23/05/22	23/05/24	70,170 sh	$1.88	$131,919.6	−18.8%